Global Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Region, Industry Analysis and Forecast, 2019 - 2025
The Global Tumor Ablation Market size is expected to reach $1.7 billion by 2025, rising at a market growth of 10.9% CAGR during the forecast period. Tumor ablation is a minimally invasive image-guided procedure that is used to treat liver, kidney, soft tissue, and bone tumors. By using heat, chemicals, and low temperature, this procedure ensures high efficacy of tumor treatment eliminating most of the possible side effects. Tumor ablation is a procedure that has achieved greater effectiveness in the treatment of tumor cells with limited toxicity or side effects. The destruction of tumors is done using heat, low temperature, and chemical agents, which are inserted through a small hole in the tumor regions with a guided needle.
The ongoing technological advancements have made tumor ablation treatment a safe and painless one especially due to impressive results during and after the procedure. With increasing awareness in the healthcare industry around the world, cancer ablation is becoming increasingly popular for different types of cancer as one of the most favored cancer therapy methods. Hospitals and healthcare centers are recognizing the immense potential of cancer ablation therapy, thereby supporting their patients with the facility that would further assist in facilitating the therapeutic.
As the trend towards decreased invasiveness of medical procedures persists, image-guided percutaneous ablation has started supplanting surgery for local control of small tumors in the liver, kidney, and lung. New ablation techniques and refinement of existing technologies will make it possible to treat larger and more complex tumors in these and other organs. At the same time, advances in intra-procedural imaging aim to boost treatment quality and complications. Advancements in intraprocedural imaging have enhanced treatment preparation and provided a more accurate assessment of the ablation zone during treatment. As these techniques mature, the reason for percutaneous ablation continues to expand and ablation appears to be gradually supplanting for local tumor therapy.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix, Medtronic PLC and Johnson and Johnson (Ethicon, Inc.) are some of the forerunners in the Tumor Ablation Market. Companies such as Boston Scientific Corporation, AngioDynamics, Inc., HealthTronics, Inc., Misonix, Inc., and EDAP TMS S.A. are some of the key innovators in Tumor Ablation Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Strategies deployed in Tumor Ablation Market
Partnerships, Collaborations, and Agreements:
Dec-2019: Misonix signed distribution agreement with CryoLife, a leading vascular and cardiac surgery company. The agreement provides Misonix with the US exclusive commercialization rights for CryoLife's NeoPatch product for the treatment of a broad range of indications outside vascular and cardiac surgery.
Oct-2017: EDAP TMS signed an agreement with Theraclion, a French HIFU company. Under the agreement, the former company distributes Echopulse system in France with the help of the latter company. Echopulse uses EDAP's proprietary HIFU technology for addressing the breast fibroadenomas and benign thyroid nodules.
Product Launches:
Aug-2018: J&J released NEUWAVE, a microwave ablation system. This is the first minimally invasive device that puts electrodes into cancer cells and increases the temperature around them for burning off the cancer cells.
Apr-2017: Medtronic Canada, a subsidiary of Medtronic PLC launched OsteoCool RF Ablation System in Canada. This is the only cooled radiofrequency (RF) ablation technology, which provides simultaneous and dual-probe capabilities. This provides a minimally-invasive option for the treatment of painful bone metastases.
Acquisition and Mergers:
Oct-2019: AngioDynamics announced the acquisition of Eximo Medical, Ltd., a medical device company. The Vascular Interventions and Therapies (VIT) product portfolio of AngioDynamics has been expanded through the addition of proprietary laser technology.
Jun-2019: Boston Scientific completed the acquisition of Vertiflex, Inc., a producer of spinal spacer implants. The acquisition expanded its portfolio of interventional pain therapies.
Apr-2019: J&J completed the acquisition of Auris Health, Inc., a surgical robotics company. The acquisition provided a lung cancer diagnostic and treatment tool to the former company. Through this acquisition, the company has been able to expand its health portfolio.
Jan-2019: Medtronic announced an agreement to acquire Epix Therapeutics, a company engaged in the manufacturing of catheter-based system for the treatment of patients with AFIB. The acquisition would expand the company's cardiac ablation portfolio.
Sep-2018: AngioDynamics acquired RadiaDyne, a medical diagnostic and device company. The company has expanded its oncology business through the addition of RadiaDyne’s early-stage, proprietary OARtrac real-time radiation dose monitoring platform, and other market-leading oncology solutions.
Jul-2018: Boston Scientific signed an agreement to acquire Cryterion Medical. The acquisition would enable the former company in providing cryothermal as well as radiofrequency (RF) single-shot, balloon-based ablation therapies.
Mar-2018: Boston Scientific acquired EMcision Ltd., a company engaged in developing and commercializing proprietary medical devices. The acquisition helped the company in improving the quality of life of cancer patients on a much larger scale.
Scope of the Study
Market Segmentation:
By Treatment
The ongoing technological advancements have made tumor ablation treatment a safe and painless one especially due to impressive results during and after the procedure. With increasing awareness in the healthcare industry around the world, cancer ablation is becoming increasingly popular for different types of cancer as one of the most favored cancer therapy methods. Hospitals and healthcare centers are recognizing the immense potential of cancer ablation therapy, thereby supporting their patients with the facility that would further assist in facilitating the therapeutic.
As the trend towards decreased invasiveness of medical procedures persists, image-guided percutaneous ablation has started supplanting surgery for local control of small tumors in the liver, kidney, and lung. New ablation techniques and refinement of existing technologies will make it possible to treat larger and more complex tumors in these and other organs. At the same time, advances in intra-procedural imaging aim to boost treatment quality and complications. Advancements in intraprocedural imaging have enhanced treatment preparation and provided a more accurate assessment of the ablation zone during treatment. As these techniques mature, the reason for percutaneous ablation continues to expand and ablation appears to be gradually supplanting for local tumor therapy.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix, Medtronic PLC and Johnson and Johnson (Ethicon, Inc.) are some of the forerunners in the Tumor Ablation Market. Companies such as Boston Scientific Corporation, AngioDynamics, Inc., HealthTronics, Inc., Misonix, Inc., and EDAP TMS S.A. are some of the key innovators in Tumor Ablation Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Strategies deployed in Tumor Ablation Market
Partnerships, Collaborations, and Agreements:
Dec-2019: Misonix signed distribution agreement with CryoLife, a leading vascular and cardiac surgery company. The agreement provides Misonix with the US exclusive commercialization rights for CryoLife's NeoPatch product for the treatment of a broad range of indications outside vascular and cardiac surgery.
Oct-2017: EDAP TMS signed an agreement with Theraclion, a French HIFU company. Under the agreement, the former company distributes Echopulse system in France with the help of the latter company. Echopulse uses EDAP's proprietary HIFU technology for addressing the breast fibroadenomas and benign thyroid nodules.
Product Launches:
Aug-2018: J&J released NEUWAVE, a microwave ablation system. This is the first minimally invasive device that puts electrodes into cancer cells and increases the temperature around them for burning off the cancer cells.
Apr-2017: Medtronic Canada, a subsidiary of Medtronic PLC launched OsteoCool RF Ablation System in Canada. This is the only cooled radiofrequency (RF) ablation technology, which provides simultaneous and dual-probe capabilities. This provides a minimally-invasive option for the treatment of painful bone metastases.
Acquisition and Mergers:
Oct-2019: AngioDynamics announced the acquisition of Eximo Medical, Ltd., a medical device company. The Vascular Interventions and Therapies (VIT) product portfolio of AngioDynamics has been expanded through the addition of proprietary laser technology.
Jun-2019: Boston Scientific completed the acquisition of Vertiflex, Inc., a producer of spinal spacer implants. The acquisition expanded its portfolio of interventional pain therapies.
Apr-2019: J&J completed the acquisition of Auris Health, Inc., a surgical robotics company. The acquisition provided a lung cancer diagnostic and treatment tool to the former company. Through this acquisition, the company has been able to expand its health portfolio.
Jan-2019: Medtronic announced an agreement to acquire Epix Therapeutics, a company engaged in the manufacturing of catheter-based system for the treatment of patients with AFIB. The acquisition would expand the company's cardiac ablation portfolio.
Sep-2018: AngioDynamics acquired RadiaDyne, a medical diagnostic and device company. The company has expanded its oncology business through the addition of RadiaDyne’s early-stage, proprietary OARtrac real-time radiation dose monitoring platform, and other market-leading oncology solutions.
Jul-2018: Boston Scientific signed an agreement to acquire Cryterion Medical. The acquisition would enable the former company in providing cryothermal as well as radiofrequency (RF) single-shot, balloon-based ablation therapies.
Mar-2018: Boston Scientific acquired EMcision Ltd., a company engaged in developing and commercializing proprietary medical devices. The acquisition helped the company in improving the quality of life of cancer patients on a much larger scale.
Scope of the Study
Market Segmentation:
By Treatment
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation and
- Other Technology
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Tumor Ablation Market, by Treatment
1.4.2 Global Tumor Ablation Market, by Technology
1.4.3 Global Tumor Ablation Market, by Application
1.4.4 Global Tumor Ablation Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. GLOBAL TUMOR ABLATION MARKET BY TREATMENT
4.1 Global Surgical Ablation Market by Region
4.2 Global Laparoscopic Ablation Market by Region
4.3 Global Percutaneous Ablation Market by Region
CHAPTER 5. GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 Global Radiofrequency Ablation Market by Region
5.2 Global Microwave Ablation Market by Region
5.3 Global Cryoablation Market by Region
5.4 Global Irreversible Electroporation Market by Region
5.5 Global Other Technology Market by Region
CHAPTER 6. GLOBAL TUMOR ABLATION MARKET BY APPLICATION
6.1 Global Liver Cancer Market by Region
6.2 Global Breast Cancer Market by Region
6.3 Global Lung Cancer Market by Region
6.4 Global Kidney Cancer Market by Region
6.5 Global Prostate Cancer Market by Region
6.6 Global Other Cancer Market by Region
CHAPTER 7. GLOBAL TUMOR ABLATION MARKET BY REGION
7.1 North America Tumor Ablation Market
7.1.1 North America Tumor Ablation Market by Treatment
7.1.1.1 North America Surgical Ablation Market by Country
7.1.1.2 North America Laparoscopic Ablation Market by Country
7.1.1.3 North America Percutaneous Ablation Market by Country
7.1.2 North America Tumor Ablation Market by Technology
7.1.2.1 North America Radiofrequency Ablation Market by Country
7.1.2.2 North America Microwave Ablation Market by Country
7.1.2.3 North America Cryoablation Market by Country
7.1.2.4 North America Irreversible Electroporation Market by Country
7.1.2.5 North America Other Technology Market by Country
7.1.3 North America Tumor Ablation Market by Application
7.1.3.1 North America Liver Cancer Market by Country
7.1.3.2 North America Breast Cancer Market by Country
7.1.3.3 North America Lung Cancer Market by Country
7.1.3.4 North America Kidney Cancer Market by Country
7.1.3.5 North America Prostate Cancer Market by Country
7.1.3.6 North America Others Tumor Ablation Market by Country
7.1.4 North America Tumor Ablation Market by Country
7.1.4.1 US Tumor Ablation Market
7.1.4.1.1 US Tumor Ablation Market by Treatment
7.1.4.1.2 US Tumor Ablation Market by Technology
7.1.4.1.3 US Tumor Ablation Market by Application
7.1.4.2 Canada Tumor Ablation Market
7.1.4.2.1 Canada Tumor Ablation Market by Treatment
7.1.4.2.2 Canada Tumor Ablation Market by Technology
7.1.4.2.3 Canada Tumor Ablation Market by Application
7.1.4.3 Mexico Tumor Ablation Market
7.1.4.3.1 Mexico Tumor Ablation Market by Treatment
7.1.4.3.2 Mexico Tumor Ablation Market by Technology
7.1.4.3.3 Mexico Tumor Ablation Market by Application
7.1.4.4 Rest of North America Tumor Ablation Market
7.1.4.4.1 Rest of North America Tumor Ablation Market by Treatment
7.1.4.4.2 Rest of North America Tumor Ablation Market by Technology
7.1.4.4.3 Rest of North America Tumor Ablation Market by Application
7.2 Europe Tumor Ablation Market
7.2.1 Europe Tumor Ablation Market by Treatment
7.2.1.1 Europe Surgical Ablation Market by Country
7.2.1.2 Europe Laparoscopic Ablation Market by Country
7.2.1.3 Europe Percutaneous Ablation Market by Country
7.2.2 Europe Tumor Ablation Market by Technology
7.2.2.1 Europe Radiofrequency Ablation Market by Country
7.2.2.2 Europe Microwave Ablation Market by Country
7.2.2.3 Europe Cryoablation Market by Country
7.2.2.4 Europe Irreversible Electroporation Market by Country
7.2.2.5 Europe Other Technology Market by Country
7.2.3 Europe Tumor Ablation Market by Application
7.2.3.1 Europe Liver Cancer Market by Country
7.2.3.2 Europe Breast Cancer Market by Country
7.2.3.3 Europe Lung Cancer Market by Country
7.2.3.4 Europe Kidney Cancer Market by Country
7.2.3.5 Europe Prostate Cancer Market by Country
7.2.3.6 Europe Others Cancer Market by Country
7.2.4 Europe Tumor Ablation Market by Country
7.2.4.1 Germany Tumor Ablation Market
7.2.4.1.1 Germany Tumor Ablation Market by Treatment
7.2.4.1.2 Germany Tumor Ablation Market by Technology
7.2.4.1.3 Germany Tumor Ablation Market by Application
7.2.4.2 UK Tumor Ablation Market
7.2.4.2.1 UK Tumor Ablation Market by Treatment
7.2.4.2.2 UK Tumor Ablation Market by Technology
7.2.4.2.3 UK Tumor Ablation Market by Application
7.2.4.3 France Tumor Ablation Market
7.2.4.3.1 France Tumor Ablation Market by Treatment
7.2.4.3.2 France Tumor Ablation Market by Technology
7.2.4.3.3 France Tumor Ablation Market by Application
7.2.4.4 Russia Tumor Ablation Market
7.2.4.4.1 Russia Tumor Ablation Market by Treatment
7.2.4.4.2 Russia Tumor Ablation Market by Technology
7.2.4.4.3 Russia Tumor Ablation Market by Application
7.2.4.5 Spain Tumor Ablation Market
7.2.4.5.1 Spain Tumor Ablation Market by Treatment
7.2.4.5.2 Spain Tumor Ablation Market by Technology
7.2.4.5.3 Spain Tumor Ablation Market by Application
7.2.4.6 Italy Tumor Ablation Market
7.2.4.6.1 Italy Tumor Ablation Market by Treatment
7.2.4.6.2 Italy Tumor Ablation Market by Technology
7.2.4.6.3 Italy Tumor Ablation Market by Application
7.2.4.7 Rest of Europe Tumor Ablation Market
7.2.4.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.2.4.7.2 Rest of Europe Tumor Ablation Market by Technology
7.2.4.7.3 Rest of Europe Tumor Ablation Market by Application
7.3 Asia Pacific Tumor Ablation Market
7.3.1 Asia Pacific Tumor Ablation Market by Treatment
7.3.1.1 Asia Pacific Surgical Ablation Market by Country
7.3.1.2 Asia Pacific Laparoscopic Ablation Market by Country
7.3.1.3 Asia Pacific Percutaneous Ablation Market by Country
7.3.2 Asia Pacific Tumor Ablation Market by Technology
7.3.2.1 Asia Pacific Radiofrequency Ablation Market by Country
7.3.2.2 Asia Pacific Microwave Ablation Market by Country
7.3.2.3 Asia Pacific Cryoablation Market by Country
7.3.2.4 Asia Pacific Irreversible Electroporation Market by Country
7.3.2.5 Asia Pacific Other Technology Market by Country
7.3.3 Asia Pacific Tumor Ablation Market by Application
7.3.3.1 Asia Pacific Liver Cancer Market by Country
7.3.3.2 Asia Pacific Breast Cancer Market by Country
7.3.3.3 Asia Pacific Lung Cancer Market by Country
7.3.3.4 Asia Pacific Kidney Cancer Market by Country
7.3.3.5 Asia Pacific Prostate Cancer Market by Country
7.3.3.6 Asia Pacific Other Cancer Market by Country
7.3.4 Asia Pacific Tumor Ablation Market by Country
7.3.4.1 China Tumor Ablation Market
7.3.4.1.1 China Tumor Ablation Market by Treatment
7.3.4.1.2 China Tumor Ablation Market by Technology
7.3.4.1.3 China Tumor Ablation Market by Application
7.3.4.2 Japan Tumor Ablation Market
7.3.4.2.1 Japan Tumor Ablation Market by Treatment
7.3.4.2.2 Japan Tumor Ablation Market by Technology
7.3.4.2.3 Japan Tumor Ablation Market by Application
7.3.4.3 India Tumor Ablation Market
7.3.4.3.1 India Tumor Ablation Market by Treatment
7.3.4.3.2 India Tumor Ablation Market by Technology
7.3.4.3.3 India Tumor Ablation Market by Application
7.3.4.4 South Korea Tumor Ablation Market
7.3.4.4.1 South Korea Tumor Ablation Market by Treatment
7.3.4.4.2 South Korea Tumor Ablation Market by Technology
7.3.4.4.3 South Korea Tumor Ablation Market by Application
7.3.4.5 Australia Tumor Ablation Market
7.3.4.5.1 Australia Tumor Ablation Market by Treatment
7.3.4.5.2 Australia Tumor Ablation Market by Technology
7.3.4.5.3 Australia Tumor Ablation Market by Application
7.3.4.6 Singapore Tumor Ablation Market
7.3.4.6.1 Singapore Tumor Ablation Market by Treatment
7.3.4.6.2 Singapore Tumor Ablation Market by Technology
7.3.4.6.3 Singapore Tumor Ablation Market by Application
7.3.4.7 Rest of Asia Pacific Tumor Ablation Market
7.3.4.7.1 Rest of Asia Pacific Tumor Ablation Market by Treatment
7.3.4.7.2 Rest of Asia Pacific Tumor Ablation Market by Technology
7.3.4.7.3 Rest of Asia Pacific Tumor Ablation Market by Application
7.4 LAMEA Tumor Ablation Market
7.4.1 LAMEA Tumor Ablation Market by Treatment
7.4.1.1 LAMEA Surgical Ablation Market by Country
7.4.1.2 LAMEA Laparoscopic Ablation Market by Country
7.4.1.3 LAMEA Percutaneous Ablation Market by Country
7.4.2 LAMEA Tumor Ablation Market by Technology
7.4.2.1 LAMEA Radiofrequency Ablation Market by Country
7.4.2.2 LAMEA Microwave Ablation Market by Country
7.4.2.3 LAMEA Cryoablation Market by Country
7.4.2.4 LAMEA Irreversible Electroporation Market by Country
7.4.2.5 LAMEA Other Technology Market by Country
7.4.3 LAMEA Tumor Ablation Market by Application
7.4.3.1 LAMEA Liver Cancer Market by Country
7.4.3.2 LAMEA Breast Cancer Market by Country
7.4.3.3 LAMEA Lung Cancer Market by Country
7.4.3.4 LAMEA Kidney Cancer Market by Country
7.4.3.5 LAMEA Prostate Cancer Market by Country
7.4.3.6 LAMEA Other Cancer Market by Country
7.4.4 LAMEA Tumor Ablation Market by Country
7.4.4.1 Brazil Tumor Ablation Market
7.4.4.1.1 Brazil Tumor Ablation Market by Treatment
7.4.4.1.2 Brazil Tumor Ablation Market by Technology
7.4.4.1.3 Brazil Tumor Ablation Market by Application
7.4.4.2 Argentina Tumor Ablation Market
7.4.4.2.1 Argentina Tumor Ablation Market by Treatment
7.4.4.2.2 Argentina Tumor Ablation Market by Technology
7.4.4.2.3 Argentina Tumor Ablation Market by Application
7.4.4.3 UAE Tumor Ablation Market
7.4.4.3.1 UAE Tumor Ablation Market by Treatment
7.4.4.3.2 UAE Tumor Ablation Market by Technology
7.4.4.3.3 UAE Tumor Ablation Market by Application
7.4.4.4 Saudi Arabia Tumor Ablation Market
7.4.4.4.1 Saudi Arabia Tumor Ablation Market by Treatment
7.4.4.4.2 Saudi Arabia Tumor Ablation Market by Technology
7.4.4.4.3 Saudi Arabia Tumor Ablation Market by Application
7.4.4.5 South Africa Tumor Ablation Market
7.4.4.5.1 South Africa Tumor Ablation Market by Treatment
7.4.4.5.2 South Africa Tumor Ablation Market by Technology
7.4.4.5.3 South Africa Tumor Ablation Market by Application
7.4.4.6 Nigeria Tumor Ablation Market
7.4.4.6.1 Nigeria Tumor Ablation Market by Treatment
7.4.4.6.2 Nigeria Tumor Ablation Market by Technology
7.4.4.6.3 Nigeria Tumor Ablation Market by Application
7.4.4.7 Rest of LAMEA Tumor Ablation Market
7.4.4.7.1 Rest of LAMEA Tumor Ablation Market by Treatment
7.4.4.7.2 Rest of LAMEA Tumor Ablation Market by Technology
7.4.4.7.3 Rest of LAMEA Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Tumor Ablation Market, by Treatment
1.4.2 Global Tumor Ablation Market, by Technology
1.4.3 Global Tumor Ablation Market, by Application
1.4.4 Global Tumor Ablation Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. GLOBAL TUMOR ABLATION MARKET BY TREATMENT
4.1 Global Surgical Ablation Market by Region
4.2 Global Laparoscopic Ablation Market by Region
4.3 Global Percutaneous Ablation Market by Region
CHAPTER 5. GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 Global Radiofrequency Ablation Market by Region
5.2 Global Microwave Ablation Market by Region
5.3 Global Cryoablation Market by Region
5.4 Global Irreversible Electroporation Market by Region
5.5 Global Other Technology Market by Region
CHAPTER 6. GLOBAL TUMOR ABLATION MARKET BY APPLICATION
6.1 Global Liver Cancer Market by Region
6.2 Global Breast Cancer Market by Region
6.3 Global Lung Cancer Market by Region
6.4 Global Kidney Cancer Market by Region
6.5 Global Prostate Cancer Market by Region
6.6 Global Other Cancer Market by Region
CHAPTER 7. GLOBAL TUMOR ABLATION MARKET BY REGION
7.1 North America Tumor Ablation Market
7.1.1 North America Tumor Ablation Market by Treatment
7.1.1.1 North America Surgical Ablation Market by Country
7.1.1.2 North America Laparoscopic Ablation Market by Country
7.1.1.3 North America Percutaneous Ablation Market by Country
7.1.2 North America Tumor Ablation Market by Technology
7.1.2.1 North America Radiofrequency Ablation Market by Country
7.1.2.2 North America Microwave Ablation Market by Country
7.1.2.3 North America Cryoablation Market by Country
7.1.2.4 North America Irreversible Electroporation Market by Country
7.1.2.5 North America Other Technology Market by Country
7.1.3 North America Tumor Ablation Market by Application
7.1.3.1 North America Liver Cancer Market by Country
7.1.3.2 North America Breast Cancer Market by Country
7.1.3.3 North America Lung Cancer Market by Country
7.1.3.4 North America Kidney Cancer Market by Country
7.1.3.5 North America Prostate Cancer Market by Country
7.1.3.6 North America Others Tumor Ablation Market by Country
7.1.4 North America Tumor Ablation Market by Country
7.1.4.1 US Tumor Ablation Market
7.1.4.1.1 US Tumor Ablation Market by Treatment
7.1.4.1.2 US Tumor Ablation Market by Technology
7.1.4.1.3 US Tumor Ablation Market by Application
7.1.4.2 Canada Tumor Ablation Market
7.1.4.2.1 Canada Tumor Ablation Market by Treatment
7.1.4.2.2 Canada Tumor Ablation Market by Technology
7.1.4.2.3 Canada Tumor Ablation Market by Application
7.1.4.3 Mexico Tumor Ablation Market
7.1.4.3.1 Mexico Tumor Ablation Market by Treatment
7.1.4.3.2 Mexico Tumor Ablation Market by Technology
7.1.4.3.3 Mexico Tumor Ablation Market by Application
7.1.4.4 Rest of North America Tumor Ablation Market
7.1.4.4.1 Rest of North America Tumor Ablation Market by Treatment
7.1.4.4.2 Rest of North America Tumor Ablation Market by Technology
7.1.4.4.3 Rest of North America Tumor Ablation Market by Application
7.2 Europe Tumor Ablation Market
7.2.1 Europe Tumor Ablation Market by Treatment
7.2.1.1 Europe Surgical Ablation Market by Country
7.2.1.2 Europe Laparoscopic Ablation Market by Country
7.2.1.3 Europe Percutaneous Ablation Market by Country
7.2.2 Europe Tumor Ablation Market by Technology
7.2.2.1 Europe Radiofrequency Ablation Market by Country
7.2.2.2 Europe Microwave Ablation Market by Country
7.2.2.3 Europe Cryoablation Market by Country
7.2.2.4 Europe Irreversible Electroporation Market by Country
7.2.2.5 Europe Other Technology Market by Country
7.2.3 Europe Tumor Ablation Market by Application
7.2.3.1 Europe Liver Cancer Market by Country
7.2.3.2 Europe Breast Cancer Market by Country
7.2.3.3 Europe Lung Cancer Market by Country
7.2.3.4 Europe Kidney Cancer Market by Country
7.2.3.5 Europe Prostate Cancer Market by Country
7.2.3.6 Europe Others Cancer Market by Country
7.2.4 Europe Tumor Ablation Market by Country
7.2.4.1 Germany Tumor Ablation Market
7.2.4.1.1 Germany Tumor Ablation Market by Treatment
7.2.4.1.2 Germany Tumor Ablation Market by Technology
7.2.4.1.3 Germany Tumor Ablation Market by Application
7.2.4.2 UK Tumor Ablation Market
7.2.4.2.1 UK Tumor Ablation Market by Treatment
7.2.4.2.2 UK Tumor Ablation Market by Technology
7.2.4.2.3 UK Tumor Ablation Market by Application
7.2.4.3 France Tumor Ablation Market
7.2.4.3.1 France Tumor Ablation Market by Treatment
7.2.4.3.2 France Tumor Ablation Market by Technology
7.2.4.3.3 France Tumor Ablation Market by Application
7.2.4.4 Russia Tumor Ablation Market
7.2.4.4.1 Russia Tumor Ablation Market by Treatment
7.2.4.4.2 Russia Tumor Ablation Market by Technology
7.2.4.4.3 Russia Tumor Ablation Market by Application
7.2.4.5 Spain Tumor Ablation Market
7.2.4.5.1 Spain Tumor Ablation Market by Treatment
7.2.4.5.2 Spain Tumor Ablation Market by Technology
7.2.4.5.3 Spain Tumor Ablation Market by Application
7.2.4.6 Italy Tumor Ablation Market
7.2.4.6.1 Italy Tumor Ablation Market by Treatment
7.2.4.6.2 Italy Tumor Ablation Market by Technology
7.2.4.6.3 Italy Tumor Ablation Market by Application
7.2.4.7 Rest of Europe Tumor Ablation Market
7.2.4.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.2.4.7.2 Rest of Europe Tumor Ablation Market by Technology
7.2.4.7.3 Rest of Europe Tumor Ablation Market by Application
7.3 Asia Pacific Tumor Ablation Market
7.3.1 Asia Pacific Tumor Ablation Market by Treatment
7.3.1.1 Asia Pacific Surgical Ablation Market by Country
7.3.1.2 Asia Pacific Laparoscopic Ablation Market by Country
7.3.1.3 Asia Pacific Percutaneous Ablation Market by Country
7.3.2 Asia Pacific Tumor Ablation Market by Technology
7.3.2.1 Asia Pacific Radiofrequency Ablation Market by Country
7.3.2.2 Asia Pacific Microwave Ablation Market by Country
7.3.2.3 Asia Pacific Cryoablation Market by Country
7.3.2.4 Asia Pacific Irreversible Electroporation Market by Country
7.3.2.5 Asia Pacific Other Technology Market by Country
7.3.3 Asia Pacific Tumor Ablation Market by Application
7.3.3.1 Asia Pacific Liver Cancer Market by Country
7.3.3.2 Asia Pacific Breast Cancer Market by Country
7.3.3.3 Asia Pacific Lung Cancer Market by Country
7.3.3.4 Asia Pacific Kidney Cancer Market by Country
7.3.3.5 Asia Pacific Prostate Cancer Market by Country
7.3.3.6 Asia Pacific Other Cancer Market by Country
7.3.4 Asia Pacific Tumor Ablation Market by Country
7.3.4.1 China Tumor Ablation Market
7.3.4.1.1 China Tumor Ablation Market by Treatment
7.3.4.1.2 China Tumor Ablation Market by Technology
7.3.4.1.3 China Tumor Ablation Market by Application
7.3.4.2 Japan Tumor Ablation Market
7.3.4.2.1 Japan Tumor Ablation Market by Treatment
7.3.4.2.2 Japan Tumor Ablation Market by Technology
7.3.4.2.3 Japan Tumor Ablation Market by Application
7.3.4.3 India Tumor Ablation Market
7.3.4.3.1 India Tumor Ablation Market by Treatment
7.3.4.3.2 India Tumor Ablation Market by Technology
7.3.4.3.3 India Tumor Ablation Market by Application
7.3.4.4 South Korea Tumor Ablation Market
7.3.4.4.1 South Korea Tumor Ablation Market by Treatment
7.3.4.4.2 South Korea Tumor Ablation Market by Technology
7.3.4.4.3 South Korea Tumor Ablation Market by Application
7.3.4.5 Australia Tumor Ablation Market
7.3.4.5.1 Australia Tumor Ablation Market by Treatment
7.3.4.5.2 Australia Tumor Ablation Market by Technology
7.3.4.5.3 Australia Tumor Ablation Market by Application
7.3.4.6 Singapore Tumor Ablation Market
7.3.4.6.1 Singapore Tumor Ablation Market by Treatment
7.3.4.6.2 Singapore Tumor Ablation Market by Technology
7.3.4.6.3 Singapore Tumor Ablation Market by Application
7.3.4.7 Rest of Asia Pacific Tumor Ablation Market
7.3.4.7.1 Rest of Asia Pacific Tumor Ablation Market by Treatment
7.3.4.7.2 Rest of Asia Pacific Tumor Ablation Market by Technology
7.3.4.7.3 Rest of Asia Pacific Tumor Ablation Market by Application
7.4 LAMEA Tumor Ablation Market
7.4.1 LAMEA Tumor Ablation Market by Treatment
7.4.1.1 LAMEA Surgical Ablation Market by Country
7.4.1.2 LAMEA Laparoscopic Ablation Market by Country
7.4.1.3 LAMEA Percutaneous Ablation Market by Country
7.4.2 LAMEA Tumor Ablation Market by Technology
7.4.2.1 LAMEA Radiofrequency Ablation Market by Country
7.4.2.2 LAMEA Microwave Ablation Market by Country
7.4.2.3 LAMEA Cryoablation Market by Country
7.4.2.4 LAMEA Irreversible Electroporation Market by Country
7.4.2.5 LAMEA Other Technology Market by Country
7.4.3 LAMEA Tumor Ablation Market by Application
7.4.3.1 LAMEA Liver Cancer Market by Country
7.4.3.2 LAMEA Breast Cancer Market by Country
7.4.3.3 LAMEA Lung Cancer Market by Country
7.4.3.4 LAMEA Kidney Cancer Market by Country
7.4.3.5 LAMEA Prostate Cancer Market by Country
7.4.3.6 LAMEA Other Cancer Market by Country
7.4.4 LAMEA Tumor Ablation Market by Country
7.4.4.1 Brazil Tumor Ablation Market
7.4.4.1.1 Brazil Tumor Ablation Market by Treatment
7.4.4.1.2 Brazil Tumor Ablation Market by Technology
7.4.4.1.3 Brazil Tumor Ablation Market by Application
7.4.4.2 Argentina Tumor Ablation Market
7.4.4.2.1 Argentina Tumor Ablation Market by Treatment
7.4.4.2.2 Argentina Tumor Ablation Market by Technology
7.4.4.2.3 Argentina Tumor Ablation Market by Application
7.4.4.3 UAE Tumor Ablation Market
7.4.4.3.1 UAE Tumor Ablation Market by Treatment
7.4.4.3.2 UAE Tumor Ablation Market by Technology
7.4.4.3.3 UAE Tumor Ablation Market by Application
7.4.4.4 Saudi Arabia Tumor Ablation Market
7.4.4.4.1 Saudi Arabia Tumor Ablation Market by Treatment
7.4.4.4.2 Saudi Arabia Tumor Ablation Market by Technology
7.4.4.4.3 Saudi Arabia Tumor Ablation Market by Application
7.4.4.5 South Africa Tumor Ablation Market
7.4.4.5.1 South Africa Tumor Ablation Market by Treatment
7.4.4.5.2 South Africa Tumor Ablation Market by Technology
7.4.4.5.3 South Africa Tumor Ablation Market by Application
7.4.4.6 Nigeria Tumor Ablation Market
7.4.4.6.1 Nigeria Tumor Ablation Market by Treatment
7.4.4.6.2 Nigeria Tumor Ablation Market by Technology
7.4.4.6.3 Nigeria Tumor Ablation Market by Application
7.4.4.7 Rest of LAMEA Tumor Ablation Market
7.4.4.7.1 Rest of LAMEA Tumor Ablation Market by Treatment
7.4.4.7.2 Rest of LAMEA Tumor Ablation Market by Technology
7.4.4.7.3 Rest of LAMEA Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
LIST OF TABLES
TABLE 1 GLOBAL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 GLOBAL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 GLOBAL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 GLOBAL SURGICAL ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 9 GLOBAL SURGICAL ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 10 GLOBAL LAPAROSCOPIC ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 11 GLOBAL LAPAROSCOPIC ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 12 GLOBAL PERCUTANEOUS ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 13 GLOBAL PERCUTANEOUS ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 14 GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 GLOBAL RADIOFREQUENCY ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 17 GLOBAL RADIOFREQUENCY ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 18 GLOBAL MICROWAVE ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 19 GLOBAL MICROWAVE ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 20 GLOBAL CRYOABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 21 GLOBAL CRYOABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 22 GLOBAL IRREVERSIBLE ELECTROPORATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 23 GLOBAL IRREVERSIBLE ELECTROPORATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 24 GLOBAL OTHER TECHNOLOGY MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 25 GLOBAL OTHER TECHNOLOGY MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 26 GLOBAL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 GLOBAL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 GLOBAL LIVER CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 29 GLOBAL LIVER CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 30 GLOBAL BREAST CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 31 GLOBAL BREAST CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 32 GLOBAL LUNG CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 33 GLOBAL LUNG CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 34 GLOBAL KIDNEY CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 35 GLOBAL KIDNEY CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 36 GLOBAL PROSTATE CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 37 GLOBAL PROSTATE CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 38 GLOBAL OTHER CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 39 GLOBAL OTHER CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 40 GLOBAL TUMOR ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 41 GLOBAL TUMOR ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 42 NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 47 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 48 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 49 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 50 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 51 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 52 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 53 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 54 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 55 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 56 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 57 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 58 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 59 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 60 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 61 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 62 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 63 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 64 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 67 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 68 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 69 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 70 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 71 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 72 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 73 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 74 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 75 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 76 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 77 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 78 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 79 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 80 US TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 81 US TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 82 US TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 83 US TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 84 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 85 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 86 US TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 87 US TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 88 CANADA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 89 CANADA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 90 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 91 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 92 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 93 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 94 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 95 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 96 MEXICO TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 97 MEXICO TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 98 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 99 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 100 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 101 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 102 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 103 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 104 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 105 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 106 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 107 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 108 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 109 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 110 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 111 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 112 EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 113 EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 114 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 115 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 116 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 117 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 118 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 119 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 120 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 121 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 122 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 123 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 124 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 125 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 126 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 127 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 128 EUROPE CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 129 EUROPE CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 130 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 131 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 132 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 133 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 134 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 135 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 136 EUROPE LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 137 EUROPE LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 138 EUROPE BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 139 EUROPE BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 140 EUROPE LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 141 EUROPE LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 142 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 143 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 144 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 145 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 146 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 147 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 148 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 149 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 150 GERMANY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 151 GERMANY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 152 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 153 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 154 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 155 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 156 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 157 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 158 UK TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 159 UK TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 160 UK TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 161 UK TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 162 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 163 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 164 UK TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 165 UK TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 166 FRANCE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 167 FRANCE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 168 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 169 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 170 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 171 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 172 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 173 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 174 RUSSIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 175 RUSSIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 176 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 177 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 178 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 179 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 180 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 181 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 182 SPAIN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 183 SPAIN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 184 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 185 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 186 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 187 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 188 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 189 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 190 ITALY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 191 ITALY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 192 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 193 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 194 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 195 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 196 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 197 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 198 REST OF EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 199 REST OF EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 200 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 201 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 202 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 203 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 204 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 205 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 206 ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 207 ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 208 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 209 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 210 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 211 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 212 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 213 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 214 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 215 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 216 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 217 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 218 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 219 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 220 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 221 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 222 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 223 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 224 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 225 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 226 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 227 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 228 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 229 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 230 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 231 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 232 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 233 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 234 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 235 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 236 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 237 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 238 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 239 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 240 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 241 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 242 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 243 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 244 CHINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 245 CHINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 246 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 247 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 248 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 249 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 250 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 251 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 252 JAPAN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 253 JAPAN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 254 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 255 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 256 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 257 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 258 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 259 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 260 INDIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 261 INDIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 262 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 263 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 264 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 265 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 266 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 267 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 268 SOUTH KOREA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 269 SOUTH KOREA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 270 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 271 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 272 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 273 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 274 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 275 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 276 AUSTRALIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 277 AUSTRALIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 278 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 279 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 280 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 281 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 282 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 283 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 284 SINGAPORE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 285 SINGAPORE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 286 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 287 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 288 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 289 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 290 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 291 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 292 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 293 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 294 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 295 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 296 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 297 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 298 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 299 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 300 LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 301 LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 302 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 303 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 304 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 305 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 306 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 307 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 308 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 309 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 310 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 311 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 312 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 313 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 314 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 315 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 316 LAMEA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 317 LAMEA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 318 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 319 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 320 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 321 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 322 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 323 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 324 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 325 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 326 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 327 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 328 LAMEA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 329 LAMEA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 330 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 331 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 332 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 333 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 334 LAMEA OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 335 LAMEA OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 336 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 337 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 338 BRAZIL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 339 BRAZIL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 340 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 341 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 342 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 343 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 344 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 345 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 346 ARGENTINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 347 ARGENTINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 348 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 349 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 350 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 351 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 352 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 353 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 354 UAE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 355 UAE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 356 UAE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 357 UAE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 358 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 359 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 360 UAE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 361 UAE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 362 SAUDI ARABIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 363 SAUDI ARABIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 364 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 365 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 366 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 367 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 368 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 369 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 370 SOUTH AFRICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 371 SOUTH AFRICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 372 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 373 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 374 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 375 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 376 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 377 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 378 NIGERIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 379 NIGERIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 380 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 381 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 382 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 383 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 384 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 385 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 386 REST OF LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 387 REST OF LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 388 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 389 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 390 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 391 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 392 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 393 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 394 KEY INFORMATION – MEDTRONIC PLC
TABLE 395 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 396 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 397 KEY INFORMATION – MISONIX, INC.
TABLE 398 KEY INFORMATION – EDAP TMS S.A.
TABLE 399 KEY INFORMATION – THERACLION SA
TABLE 400 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 401 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 402 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 403 KEY INFORMATION – SONACARE MEDICAL, LLC
TABLE 1 GLOBAL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 GLOBAL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 GLOBAL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 GLOBAL SURGICAL ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 9 GLOBAL SURGICAL ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 10 GLOBAL LAPAROSCOPIC ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 11 GLOBAL LAPAROSCOPIC ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 12 GLOBAL PERCUTANEOUS ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 13 GLOBAL PERCUTANEOUS ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 14 GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 GLOBAL RADIOFREQUENCY ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 17 GLOBAL RADIOFREQUENCY ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 18 GLOBAL MICROWAVE ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 19 GLOBAL MICROWAVE ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 20 GLOBAL CRYOABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 21 GLOBAL CRYOABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 22 GLOBAL IRREVERSIBLE ELECTROPORATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 23 GLOBAL IRREVERSIBLE ELECTROPORATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 24 GLOBAL OTHER TECHNOLOGY MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 25 GLOBAL OTHER TECHNOLOGY MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 26 GLOBAL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 GLOBAL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 GLOBAL LIVER CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 29 GLOBAL LIVER CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 30 GLOBAL BREAST CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 31 GLOBAL BREAST CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 32 GLOBAL LUNG CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 33 GLOBAL LUNG CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 34 GLOBAL KIDNEY CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 35 GLOBAL KIDNEY CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 36 GLOBAL PROSTATE CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 37 GLOBAL PROSTATE CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 38 GLOBAL OTHER CANCER MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 39 GLOBAL OTHER CANCER MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 40 GLOBAL TUMOR ABLATION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 41 GLOBAL TUMOR ABLATION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 42 NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 47 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 48 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 49 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 50 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 51 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 52 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 53 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 54 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 55 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 56 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 57 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 58 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 59 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 60 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 61 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 62 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 63 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 64 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 67 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 68 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 69 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 70 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 71 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 72 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 73 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 74 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 75 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 76 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 77 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 78 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 79 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 80 US TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 81 US TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 82 US TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 83 US TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 84 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 85 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 86 US TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 87 US TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 88 CANADA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 89 CANADA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 90 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 91 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 92 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 93 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 94 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 95 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 96 MEXICO TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 97 MEXICO TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 98 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 99 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 100 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 101 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 102 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 103 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 104 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 105 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 106 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 107 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 108 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 109 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 110 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 111 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 112 EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 113 EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 114 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 115 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 116 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 117 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 118 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 119 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 120 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 121 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 122 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 123 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 124 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 125 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 126 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 127 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 128 EUROPE CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 129 EUROPE CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 130 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 131 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 132 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 133 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 134 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 135 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 136 EUROPE LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 137 EUROPE LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 138 EUROPE BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 139 EUROPE BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 140 EUROPE LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 141 EUROPE LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 142 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 143 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 144 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 145 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 146 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 147 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 148 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 149 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 150 GERMANY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 151 GERMANY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 152 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 153 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 154 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 155 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 156 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 157 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 158 UK TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 159 UK TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 160 UK TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 161 UK TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 162 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 163 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 164 UK TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 165 UK TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 166 FRANCE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 167 FRANCE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 168 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 169 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 170 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 171 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 172 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 173 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 174 RUSSIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 175 RUSSIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 176 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 177 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 178 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 179 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 180 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 181 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 182 SPAIN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 183 SPAIN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 184 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 185 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 186 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 187 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 188 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 189 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 190 ITALY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 191 ITALY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 192 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 193 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 194 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 195 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 196 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 197 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 198 REST OF EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 199 REST OF EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 200 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 201 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 202 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 203 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 204 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 205 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 206 ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 207 ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 208 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 209 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 210 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 211 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 212 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 213 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 214 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 215 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 216 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 217 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 218 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 219 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 220 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 221 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 222 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 223 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 224 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 225 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 226 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 227 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 228 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 229 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 230 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 231 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 232 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 233 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 234 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 235 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 236 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 237 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 238 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 239 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 240 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 241 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 242 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 243 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 244 CHINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 245 CHINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 246 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 247 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 248 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 249 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 250 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 251 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 252 JAPAN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 253 JAPAN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 254 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 255 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 256 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 257 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 258 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 259 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 260 INDIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 261 INDIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 262 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 263 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 264 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 265 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 266 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 267 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 268 SOUTH KOREA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 269 SOUTH KOREA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 270 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 271 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 272 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 273 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 274 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 275 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 276 AUSTRALIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 277 AUSTRALIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 278 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 279 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 280 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 281 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 282 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 283 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 284 SINGAPORE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 285 SINGAPORE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 286 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 287 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 288 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 289 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 290 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 291 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 292 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 293 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 294 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 295 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 296 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 297 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 298 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 299 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 300 LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 301 LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 302 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 303 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 304 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 305 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 306 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 307 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 308 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 309 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 310 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 311 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 312 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 313 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 314 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 315 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 316 LAMEA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 317 LAMEA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 318 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 319 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 320 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 321 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 322 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 323 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 324 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 325 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 326 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 327 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 328 LAMEA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 329 LAMEA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 330 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 331 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 332 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 333 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 334 LAMEA OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 335 LAMEA OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 336 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 337 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 338 BRAZIL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 339 BRAZIL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 340 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 341 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 342 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 343 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 344 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 345 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 346 ARGENTINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 347 ARGENTINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 348 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 349 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 350 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 351 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 352 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 353 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 354 UAE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 355 UAE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 356 UAE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 357 UAE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 358 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 359 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 360 UAE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 361 UAE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 362 SAUDI ARABIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 363 SAUDI ARABIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 364 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 365 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 366 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 367 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 368 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 369 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 370 SOUTH AFRICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 371 SOUTH AFRICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 372 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 373 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 374 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 375 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 376 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 377 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 378 NIGERIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 379 NIGERIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 380 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 381 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 382 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 383 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 384 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 385 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 386 REST OF LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 387 REST OF LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 388 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 389 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 390 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 391 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 392 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 393 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 394 KEY INFORMATION – MEDTRONIC PLC
TABLE 395 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 396 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 397 KEY INFORMATION – MISONIX, INC.
TABLE 398 KEY INFORMATION – EDAP TMS S.A.
TABLE 399 KEY INFORMATION – THERACLION SA
TABLE 400 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 401 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 402 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 403 KEY INFORMATION – SONACARE MEDICAL, LLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
